List of Flatiron RWE Library Customers
New York, 10013, NY,
United States
Since 2010, our global team of researchers has been studying Flatiron RWE Library customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Flatiron RWE Library for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Flatiron RWE Library for Analytics and BI include: Eli Lilly, a United States based Life Sciences organisation with 50605 employees and revenues of $65.18 billion, Bristol Myers Squibb, a United States based Life Sciences organisation with 34100 employees and revenues of $48.30 billion, Foundation Medicine, a United States based Life Sciences organisation with 1800 employees and revenues of $200.0 million and many others.
Contact us if you need a completed and verified list of companies using Flatiron RWE Library, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Flatiron RWE Library customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol Myers Squibb | Life Sciences | 34100 | $48.3B | United States | Flatiron | Flatiron RWE Library | Analytics and BI | 2018 | n/a |
In 2018, Bristol Myers Squibb implemented Flatiron RWE Library as part of an expanded three-year collaboration with Flatiron Health, adopting the platform within an Analytics and BI context to support oncology real-world evidence generation. The Flatiron RWE Library was positioned to centralize oncology electronic health record derived data and to accelerate RWE production for cancer research and evidence development.
Configuration emphasized curated oncology datasets, cohort discovery and longitudinal patient records, standardized clinical data models, and analytic query and export functions to support downstream statistical and epidemiologic analysis. Flatiron RWE Library capabilities that were surfaced include cohort definition, temporal event sequencing, and metadata tagging to enable reproducible research workflows and consistent data curation across projects.
Deployment followed a managed Flatiron service model with centralized data provisioning and role based access designed for BMS research, clinical development, epidemiology and HEOR teams. Governance was implemented through joint data access agreements, privacy and compliance controls, and coordinated workflows for data request, curation and analytic handoff between Flatiron and Bristol Myers Squibb.
|
 |
Eli Lilly | Life Sciences | 50605 | $65.2B | United States | Flatiron | Flatiron RWE Library | Analytics and BI | 2015 | n/a |
In 2015, Eli Lilly implemented Flatiron RWE Library as an Analytics and BI deployment to support translational medicine research in the KRAS non small cell lung cancer setting. The implementation was led by a company medical expert and the translational medicine department, and it executed study concept initiation, protocol writing, and publication submission as one of the first uses by the company of the Flatiron EMR database to address a gap in real world evidence.
The Flatiron RWE Library deployment focused on analytics and observational study workflows typical of Analytics and BI solutions, including cohort definition, study protocol management, and analytic reporting to support publication. Integrations explicitly included use of the Flatiron EMR database to source clinical data for cohort curation and study execution. Governance and operational control rested with medical leadership and translational medicine, which directed protocol authorship and the publication submission process as part of the implementation.
|
 |
Foundation Medicine | Life Sciences | 1800 | $200M | United States | Flatiron | Flatiron RWE Library | Analytics and BI | 2017 | n/a |
In 2017, Foundation Medicine implemented the Flatiron RWE Library, an Analytics and BI application, to operationalize real world clinico genomic datasets alongside internal laboratory and clinical trial data. The deployment was oriented toward enabling regulatory and biomarker evidence workflows, with explicit effort to explore the application of real world evidence in regulatory submissions for companion diagnostics.
The implementation focused on data ingestion and harmonization capabilities, configuring the Flatiron RWE Library to consolidate clinical, genomic, sample provenance, and biomarker data into analysis ready datasets. Functional workflows supported cohort generation and analytic dataset provisioning for statisticians and scientists, and the platform was used to prepare data for analytical validation and clinical validation studies for NGS based in vitro companion diagnostics devices.
Integration scope included internal lab process data, sample level genomic files, clinical trial records, and external real world data sources through the Flatiron/Foundation Medicine collaboration. Operational coverage centered on the clinical platform, data management and biometrics teams in Cambridge Massachusetts, and downstream delivery of molecular information to pharmaceutical partners and academic collaborators.
Governance and process changes were led by Foundation Medicine data management, which managed a team of data managers, engineers, and developers to ensure datasets, programs, and documentation were archived and audit ready. The team interacted with biostatisticians to derive variables and reformat merged datasets, and contributed to regulatory submission packages including PMA, sPMA, and PMC filings to authorities such as FDA and PMDA.
Outcomes explicitly tied to the program include support for large scale, multiple study data management for FoundationOne CDx, which received approval at the end of 2017, and continued use of the Flatiron RWE Library to investigate regulatory use cases for real world evidence.
|
Buyer Intent: Companies Evaluating Flatiron RWE Library
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||